SERES THERAPEUTICS INC (MCRB)

US81750R1023 - Common Stock

0.9199  0 (-0.49%)

After market: 0.886 -0.03 (-3.69%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
126.86M126.33M7.10M144.90M33.20M
Operating Expenses
200.51M234.31M253.60M209.40M121.30M
Research and Development
120.92M144.41M166.80M141.90M90.60M
Selling, General, and Administrative Expenses
80.26M89.19M85.80M69.30M30.80M
Operating Income
-73.75M-107.98M-246.50M-64.50M-88.10M
Interest Income/Expense
-7.97M-5.88M-3.00M0.00-2.00M
Other Income/Expense
2.30M1.76M-700.00K-1.00M1.00M
Non Recurring Items
N/A-1.63MN/A0.000.00
Income Before Taxes
-82.68M-113.72M-250.20M-65.60M-89.10M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-82.68M-113.72M-250.20M-65.60M-89.10M
EBITDA
-67.34M-101.74M-239.87M-58.55M-81.52M
 
Per Share Data
EPS Diluted Total Ops
-0.60-0.89-2.31-0.72-1.12
Non GAAP EPS
-0.60-0.90-2.34-0.72-1.15
 
Statistics
Profit Margin
-65.17%-90.02%-3523.94%-45.27%-268.37%
Operating Profit Margin
-58.13%-85.48%-3471.83%-44.51%-265.36%

All data in USD

Charts